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ABSTRACT
Over the last 30 years, the pathogenesis of osteomyelitis has almost been totally elucidated, and many 
factors responsible for the persistence of this infection have been identifi ed. Numerous antimicrobial 
agents with distinct spectrums of action, pharmacokinetics, and pharmacodynamics have been used 
in its treatment. Surgical techniques, including muscle grafts, the Ilizarov technique, and antibiotic 
bone cements, have been applied. However, bone infections are still a challenge. Despite the impor-
tance of isolation and identifi cation of microorganisms to determine the antimicrobial treatment 
of bone infections, there are few systematic national studies about the etiological profi le of these 
diseases. This article describes the current knowledge of osteomyelitis and summarizes published 
national data based on the experience of different Orthopedic and Traumatology Services. In gen-
eral, S. aureus was described as an important etiological agent; however, the difference in design of 
national studies makes a comparison between the prevalence of bone infection, the associated risk 
factors, and the different therapeutic approaches diffi cult. In conclusion, effort is necessary in order 
to stimulate systematic national studies in different Orthopedics and Traumatology Services to ob-
tain a better consensus on preventive measures and therapies of bone infections.
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[Braz J Infect Dis 2010;14(3):310-315]©Elsevier Editora Ltda.
INTRODUCTION
Osteomyelitis is a progressive infection that 
results in inﬂ ammatory destruction, necrosis, 
and bone neoformation, which can progress to 
a chronic and persistent stage.1 However, it is 
not a single entity; this disease is differentiated 
according to the etiology, pathogenesis, and de-
gree of bone involvement, as well as age and the 
immune condition of the patient.2 It can involve 
different structures such as the bone marrow, 
cortex, periosteum, and parts of the surround-
ing soft tissues, or remain localized. Given this 
heterogeneity, several methods of classifi cation 
have been proposed. However, the models of 
Waldvogel et al.3 and of Cierny-Mader4 are the 
most accepted.5 Waldvogel’s system is based on 
duration, mechanism of infection, and presence 
of vascular insuffi ciency, providing the follow-
ing classifi cation: a) acute hematogenic osteo-
myelitis; b) osteomyelitis by contiguity, with or 
without vascular inadequacy; c) vertebral os-
teomyelitis; and d) chronic osteomyelitis.3 On 
the other hand, the Cierny-Mader’s classifi ca-
tion is focused on the portion of the affected 
bone and the physiological state of the host, 
including local (chronic lymphedema, venous 
stasis, retained foreign bodies, etc.) and sys-
temic risk factors (tobacco abuse, immune 
defi ciencies, malnutrition, etc.).3-7 According 
to Sia & Berbari.5 the latter classifi cation has 
more evident clinical signifi cance in treat-
ment and prognosis of osteomyelitis, since 
it is more comprehensive, including consid-
erations of other risk factors besides patient’s 
bone injury. Regardless of the model adopted, 
the distinct types of osteomyelitis require dif-
ferent clinical and surgical therapeutic strat-
egies. The most common bone infections in 
decreasing order are: osteomyelitis secondary 
to a contiguous-focus of infection or by direct 
inoculation (contamination after trauma or 
due to surgery); osteomyelitis due to vascu-
lar insuffi ciency and infection of surrounding 
soft tissues with the bone initially unaffected, 
including diabetic foot, and, fi nally, infections 
originating from the bloodstream in which 
the origin of the infection is distant.5,8 Blood-
stream-sourced infections generally involve 
the metaphysis of long bones in children or 
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vertebral bodies in adults.2,9,10 While the incidence of acute 
hematogenous osteomyelitis has been reducing in un-
der 13-year-old children,11,12 bone infections by direct 
inoculation have increased over the last decades. This is 
probably due to high-energy accidents and the growing 
use of orthopedic fixation devices and joint prostheses.13 
When genders are compared, men present with a higher 
rate of contiguous-focus osteomyelitis.14 In fact, men 
are more frequently involved in automobile accidents, 
which tend to cause exposed fractures with consequent 
high rates of infection.15
Microbial etiology of osteomyelitis
Bone tissue is relatively resistant to infection. However, os-
teomyelitis may occur after a great inoculation of microor-
ganisms or even by a small inoculation of particularly viru-
lent bacteria. Thus, the occurrence, type, severity, and the 
prognosis of osteomyelitis depends on the inter-relationship 
of a triad composed of characteristics inherent to the infec-
tion, the host, and the infecting pathogen.12
Table 1 shows osteomyelitis according to the type, age/
susceptibility factors of the host, and microbial etiology. 
Hematogenous osteomyelitis is generally monomicrobial, 
Table 1. Osteomyelitis according to type, age/susceptibility factors of the host and microbial etiology (in bold, 
the most frequent situation and isolated microorganisms) 
Types of osteomyelitis Age/Susceptibility factors Etiology
Bloodstream-sourced 
  Adults Staphylococcus aureus
  Newborn babies Enterobacteriaceae, Streptococcus agalactiae
  Children S. aureus, Streptococcus pyogenes, Group B  
  streptococci, Haemophilus influenzae
  Sickle cell disease Salmonella spp., S. aureus
  Intravenous drug abuse S. aureus, Pseudomonas. aeruginosa, Candida spp.
Vertebral 
  Adults S. aureus
  Urinary infection Aerobic gram-negative bacilli, Enterococcus spp.
  Injectable drug users P. aeruginosa, S. aureus,
  Serratia marcescens
  Spinal column surgery Coagulase-negative staphylococci, 
  S. aureus, aerobic gram-negative bacilli
  Infection of vascular devices Candida spp.
  Endemicity M. tuberculosis, Brucella spp.
Contiguous-focus 
  Diabetes mellitus, vascular  Polymicrobial: S. aureus, coagulase-negative  
 insufficiency, contaminated staphylococci, Streptococcus spp., Enterococcus  
 exposed fracture spp., gram-negative bacilli, anaerobic
  Contamination of the soil  Clostridium spp., Bacillus spp., 
  Stenotrophomonas maltophilia,
  Nocardia spp., atypical mycobacteria, 
  Aspergillus spp., Rhizopus spp., Mucor spp.
  Orthopedic fixation devices S. aureus, coagulase-negative staphylococcus,  
  Propionibacterium spp.
  Human or animal bites Pasteurella multocida, Eikenella corrodens 
  Foot lesion by sharp object or nail P. aeruginosa
  Previous periodontal infection Actinomyces spp.
  Hospitalization (nosocomial source) Enterobacteriaceae, P. aeruginosa, Candida spp.
Chronic    
  Fractures  S. aureus
  Ischemic ulcers (diabetes mellitus; Gram-negative bacilli, anerobe bacteria
 sickle cell disease; malnutrition)
Adapted from Mackowiak et al., 1978,44 and Lew & Waldvogel, 2004.8
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that is, a single bacterial species is isolated at the infection 
site.3,16,17 Among newborn babies, the most common bac-
teria found in bone infections are Streptococcus agalactiae 
and Escherichia coli, while S. aureus, Streptococcus pyogenes, 
and Haemophilus infl uenzae predominate in children. The 
incidence of osteomyelitis by H. infl uenzae has reduced af-
ter the introduction of routine active immunization during 
childhood.12 S. aureus is the most common microorganism 
isolated in adults, while other pathogens are less frequently 
found including Enterococcus spp., Streptococcus spp., Pseu-
domonas aeruginosa, Enterobacter spp., Mycobacterium spp., 
anaerobes, and fungi, specifi cally Candida spp.10
In vertebral osteomyelitis, although S. aureus is the pre-
dominant agent, gram-negative bacilli are frequently detected 
and may originate from the urinary tract and via injected 
drugs. In this setting, the incidences of P. aeruginosa and Ser-
ratia marcescens are high.18,19 In contiguous-focus osteomyeli-
tis, with a notable polymicrobial etiology, S. aureus and co-
agulase-negative staphylococci are most commonly isolated, 
corresponding to 75% of the etiological agents,3,16,17 as well as 
gram-negative bacilli and anaerobic organisms. High rate of 
nasal and skin colonization by S. aureus, immunity disorders, 
and irregular scaring of pre-existent wounds are important 
in infections involving diabetic foot. This is understandable, 
since the skin lesions caused by superfi cial fungal infections, 
most common in these patients, represent a bacterial entry.20
S. aureus is the typical pathogen responsible for both 
acute and chronic osteomyelitis by forming a biofi lm, with 
potential to rapidly develop antimicrobial resistance and ex-
pression of virulence factors, regardless of patient’s immune 
status. In these cases, surgical intervention is necessary to 
control the infection. This bacterium is a member of the 
normal ﬂ ora of the human nasal cavity with, approximately, 
20% of people within a population colonized by these mi-
croorganisms in a persistent manner, while another 60% are 
transiently colonized.21 Due to its high virulence, S. aureus 
may cause several diseases, from localized superfi cial infec-
tions, such as skin infections, to the most severe forms of 
bacteremia, such as septic arthritis, endocarditis, and sep-
tic shock syndrome. This situation becomes more complex 
with the emergence of multiple drug-resistant strains, in 
particular methicillin- and vancomycin-resistant strains 
that are endemic in hospital setting. In addition, communi-
ty-acquired strains with reduced drug susceptibility or even 
resistant have been reported.22,23 Antimicrobial resistance 
results in a delay in specifi c therapy, increasing the risk of 
disease chronifi cation and of periprosthetic infection.12
Infections subsequent to stabilization of fractures or im-
plants of joint prostheses are devastating complications dif-
fi cult to treat. Prosthetic implants, which alters the environ-
ment, including local immunity, favors bacterial invasion. 
After the trauma, lesions of soft tissues, with decreased vascu-
larization surrounding the fracture site and delayed healing, 
are important. As for bone and/or osteoarticular grafts, the 
success depends on biointegration between the metal implant 
and the bone by the formation of a tissue interface of host cells. 
However, the same phenomenon of adhesion and cell growth 
is promoted by some bacteria, in particular S. aureus, which, 
due to competition, impair biointegration. Early diagnosis and 
aggressive treatment of post-traumatic and periprosthetic bone 
infections with antibiotics, debridement, and/or stabilization of 
the internal fi xation are essential for the success of treatment. 
Thus, it is common for surgeons to be faced with the dilemma 
between treatment of infection, which may require implant re-
moval, and treatment of bone (fracture) or osteoarticular dis-
ease, which, in turn, requires implant maintenance.13
Post-arthroplasty infections are diffi cult to diagnose 
and treat and are associated with high morbidity and sub-
stantial costs. Advanced microbiological methods and novel 
imaging examinations have contributed to improvements 
in this therapy.24 The incidence of post-arthroplasty infec-
tions is 1.5% to 2.5% for primary interventions; however, 
higher rates have been reported for revision surgeries (2% 
to 20%).25 A consensual classifi cation of periprosthetic in-
fections has not been established yet, but they can be de-
fi ned according to postoperative period in three types: early-
onset, delayed-onset, or late-onset. Early manifestations are 
defi ned by the emergence of signs and symptoms within the 
fi rst three post-arthroplasty months, although some authors 
limit this period to the fi rst two to four weeks. Delayed-
onset manifests between three months and two years, while 
late-onset evolves more than two years after surgery.26-28 In 
early- and delayed-onset infections, the microorganisms can 
colonize the implant by direct inoculation during surgical 
intervention, while late-onset infections generally appear via 
the bloodstream.27,29 S. aureus and S. epidermidis correspond 
to 65% of pathogens that cause these infections, although 
other agents may also reach the prosthetic surface.28,30 Hence, 
procedures performed close to the genito-urinary and gas-
trointestinal tracts are the source of gram-negative bacilli, 
enterococci, and anaerobic organisms; similarly, dental and 
gum treatment are the source to the dissemination of Strep-
tococcus viridans, Peptococcus spp. and Peptostreptococcus 
spp., as well as pyogenic skin infections, the classical source 
of Streptococcus spp.31 Additionally, bone disease due to my-
cobacterial infections, multiple microbial infections, and in-
fections caused by uncommon pathogens, such as Candida 
spp., Brucella spp., have been reported.27,32,33 
Clinical-epidemiological proﬁ le of osteomyelitis in 
Brazil
Despite the importance of isolation and identifi cation of mi-
croorganisms to determine antimicrobial treatment of bone 
infections, there are few systematic national studies on the 
etiological profi le of these diseases. After an extensive review 
of publications in the Medline and SciELO databases, only 
nine articles published on this subject in Brazilian popula-
tions over the last 13 years were found. These works describe 
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specifi c clinical situations particular to each of the Ortho-
pedics and Traumatology Services. Thus, standardization of 
a treatment protocol for osteomyelitis remains a challenge.
Table 2 summarizes published national data related to bone 
infections after exposed fractures or consequent to arthroplasty 
(knee and hip) and the main clinical-epidemiological factors 
Table 2. Main clinical-epidemiological factors of bone infections after trauma and arthroplasty according to 
data from different Orthopedics and Traumatology Services in the state of São Paulo
Author n Fracture/ Period Frequency  Risk factors  Infectious agent Therapy
(year)  Prosthesis
Lima      - Volume of  Surgical 
et al.  Exposed fractures 02/1998  transfused blood - debridement 
2004 134 of the lower 05/2000 40.3% - ASA III  and
  limbs   - Immediate internal  antimicrobial 
     fixation of bone  therapy
     - Femur
     - Open wound 
Muller.   Exposed fractures 2000    Antimicrobial
et al 117   20.5%* NE NE** therapy and
2003  Diverse bones 2002    external fixation
Lima   Total hip  1993  Operative time P. aeruginosa Surgical
et al. 46 arthroplasty  15.1% greater than Coagulase-negative debridement
2001   1995  140 minutes staphylococci
      Morganella morgani
      Acinetobacter calcoaceticus 
      Staphylococcus spp.
      P. aeruginosa
      E. coli 
Rudelli   Total hip 1989   S. aureus One-stage
et al.   arthroplasty  ¶ NE Coagulase-negative revision
2008 32  2000   staphylococci with bone
      Enterococcus faecalis graft
      E. coli Empiric and 
      Peptostretococcus spp. directed  
      Acinetobacter spp. antibiotic
      Streptococcus mitis therapy
Leonhardt  Total knee  2003   Oxacillin-sensitive Revision of prosthesis
et al.   arthroplasty  8.3% NE S. aureus *** in two stages, 
2006 12  2004    and after six 
       months of spacer
       and antimicrobial 
       therapy
Queiroz   Total knee  01/1991    S. aureus Arthroplasty,
& Luzo 250 arthroplasty  6% NE Enterobacter spp debridement
1996   06/1995   S. epidermidis and maintenance 
      Klebsiella spp. of the prosthesis, 
      P. aeruginosa arthrodesis, resection  
       of the prosthesis, use of  
       cement with gentamicin  
       and revision surgery
NE, not evaluated.
*Acute phase infection.
**Isolation of microorganisms at time of admittance, before surgical debridement.
***The only published data on sensitivity profile.
¶ All patients underwent one-stage revision of loose and infected hip arthroplasty.
Souza Jorge, Chueire, Rossit et al.
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involved, all of which were obtained in Orthopedics and 
Traumatology Services in the state of São Paulo. In general, 
S. aureus was described as an important etiological agent; 
however, the difference in national study designs makes 
comparison between prevalence of bone infection, asso-
ciated risk factors, and different therapeutic approaches 
difficult. Only two studies referred to the frequency of 
post-fracture osteomyelitis, which ranged from 20.5%15 
to 40.3%34 in different services. Lima et al.34 reported the 
following risk factors: volume of transfused blood, ASA 
level III clinical classification, immediate internal fixa-
tion of the bone, femur fractures, and the presence of an 
open wound. The microbiological profile of infections 
was not described in these studies. In respect to hip ar-
throplasties, a single study reported the infection rate of 
around 15%,35 higher than the percentage described for 
arthroplasties of the knee (6% to 8%) reported by two 
other groups.36,37 As for risk factors in hip arthroplasties, 
operative times greater than 140 minutes were identified 
as significant.35 Gram-positive cocci, with predominance 
of S. aureus, were the most commonly isolated microor-
ganisms after arthroplasties of the knee and hip.36-38 In 
a single study, coagulase-negative staphylococci, Pseu-
domonas aeruginosa, and Acinetobacter calcoaceticus were 
equally implicated as etiological agents of infection af-
ter hip arthroplasties.35 In a different approach involving 
one-stage revision in 32 patients with loose and infected 
hip arthroplasties, Rudelli et al. (2008)39 found coagula-
se-negative staphylococci as the mainly isolated bacteria. 
On the other hand, a great diversity of Gram-negative 
bacteria (eleven different species – totaling 31.5% of all 
the agents isolated) was described by Cabrita et al.38 in 
infections after hip arthroplasties. For further informa-
tion on bone infections data in Brazil, we do recommend 
two review articles on osteomyelitis diagnosis and treat-
ment and also on infection following total knee joint ar-
throplasty by Lima & Zumiotti (1999)40 and Lima et al. 
(2004),41 respectively. 
The availability of surgical techniques and leading-
edge bone devices, combined with more accurate diag-
nosis has provided better treatment and an increased life 
expectancy of patients with osteoarticular and multiple-
trauma diseases. In this regard, the incessant occurrence 
of bone infections is a motive of frustration for both sur-
geons and patients.8 Among the causes of this lack of suc-
cess is the insufficient evidence that supports efficacious 
antimicrobial therapies for osteomyelitis.42 The choice of 
antibiotics, although limited by the sensitivity of etiologi-
cal agents, should also be based on the choice of appro-
priate via of administration, safety of long-term use, and 
cost.43 The heterogeneity among populations of patients 
and the multiplicity of clinical and surgical therapeutic 
options were also reported as complications in the reduc-
tion of bone infection rates.39 Hence, only a multidisci-
plinary approach of orthopedic surgeons, infectologists, 
radiologists, and vascular and plastic surgeons, as well as 
rheumatologists will improve therapeutic outcomes.3,24
In conclusion, effort is necessary in order to stimulate 
systematic national studies in different Orthopedics and 
Traumatology Services to obtain a better consensus on pre-
ventive measures and therapies of bone infections.
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